ANI Pharmaceuticals | 销售和管理费用



Selling And Administration Expenses 更改 日
AbbVie USD 3.25B 40M 2025-06
ANI Pharmaceuticals USD 81.77M 5.24M 2025-06
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Canopy Growth CAD 40.62M 308K 2024-12
Eli Lilly USD 2.75B 390.8M 2025-06
Hikma Pharmaceutical USD 288M 8M 2024-12
Knight Therapeutics CAD 25.48M 119K 2024-09
Novartis USD 3.5B 368M 2024-12
Perrigo USD 273.1M 8.1M 2025-06
Sun Pharmaceuticals INR 24.89B 637.6M 2025-03
Teva Pharmaceutical Industries USD 959M 40M 2025-06


ANI Pharmaceuticals 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Aug 2025.